Advertisement
Screener

TELEFLEX INCORPORATED (TFX) Overview

TELEFLEX INCORPORATED (TFX) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 2.28; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.18; Beat / miss (m).
  • 29 Sept 2025: Period ending 31 Dec 2025; Estimate (m); Actual -16.15; Beat / miss (m).
  • 30 Jun 2025: Period ending 28 Sept 2025; Estimate (m); Actual -9.24; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$95.32$105.52$116.80$129.29$143.11$158.412025-11-062026-11-06$95.32$125.25$164.57$216.23$284.12$373.322021-11-082026-11-06$95.32$131.54$181.52$250.49$345.66$476.992016-11-072026-11-06$36.24$62.98$109.45$190.21$330.55$574.432006-11-062026-11-06$1.05$3.94$14.74$55.09$205.95$769.921980-03-172026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$150.87
Previous close
$126.32
Change
$24.55
Change (%)
19.43%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

TFX
+4.33%
S&P 500
(m)

1 year

TFX
+5.86%
S&P 500
(m)

3 years

TFX
-33.92%
S&P 500
(m)

5 years

TFX
-65.95%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 2.28

-16.23-11.43-6.64-1.842.9529 Jun 2025: estimate (m); actual 2.7729 Jun 2025(m)28 Sept 2025: estimate (m); actual -9.2428 Sept 2025(m)31 Dec 2025: estimate (m); actual -16.1531 Dec 2025(m)31 Mar 2026: estimate (m); actual -0.1831 Mar 2026(m)30 Jun 2026: estimate (m); actual 2.2830 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)2.28(m)(m)
1 Jan 202631 Mar 2026(m)-0.18(m)(m)
29 Sept 202531 Dec 2025(m)-16.15(m)(m)
30 Jun 202528 Sept 2025(m)-9.24(m)(m)
31 Mar 202529 Jun 2025(m)2.77(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -20.25

-20.33-12.64-4.962.7310.4131 Dec 2021: estimate (m); actual 10.2331 Dec 2021(m)31 Dec 2022: estimate (m); actual 7.6831 Dec 2022(m)31 Dec 2023: estimate (m); actual 7.5331 Dec 2023(m)31 Dec 2024: estimate (m); actual 1.4831 Dec 2024(m)31 Dec 2025: estimate (m); actual -20.2531 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-20.25(m)(m)
1 Jan 202431 Dec 2024(m)1.48(m)(m)
1 Jan 202331 Dec 2023(m)7.53(m)(m)
1 Jan 202231 Dec 2022(m)7.68(m)(m)
1 Jan 202131 Dec 2021(m)10.23(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 570.33M ■ Earnings 99.69M — Profit margin 17.48%

-868.49M-126.5%-337.50M-78.2%193.50M-29.9%724.49M18.5%28 Sept 2025: revenue 566.95M; earnings -408.89M; profit margin -72.12%28 Sept 202531 Dec 2025: revenue 568.98M; earnings -714.33M; profit margin -125.54%31 Dec 202531 Mar 2026: revenue 548.26M; earnings -8.15M; profit margin -1.49%31 Mar 202630 Jun 2026: revenue 570.33M; earnings 99.69M; profit margin 17.48%30 Jun 2026

31 Dec 2025 ■ Revenue 1.99B ■ Earnings -0.91B — Profit margin -45.45%

-1.35B-46.4%0.18B-23.7%1.71B-0.9%3.23B21.9%31 Dec 2022: revenue 2.79B; earnings 0.36B; profit margin 13.01%31 Dec 202231 Dec 2023: revenue 1.71B; earnings 0.36B; profit margin 20.88%31 Dec 202331 Dec 2024: revenue 1.70B; earnings 0.07B; profit margin 4.13%31 Dec 202431 Dec 2025: revenue 1.99B; earnings -0.91B; profit margin -45.45%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$150.87(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$150.87High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning TFX

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-1.03B
Profit margin
-45.76%
Return on assets · 12 month
-14.57%
Index membership
(m)
Employees
15.50K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
838.50K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
1.14%*
Total return · month
-9.56%*
Total return · quarter
-0.67%*
Total return · half year
9.24%*
Total return · year to date
4.33%*
Total return · 1 year
5.86%*
Total return · 3 years
-33.92%*
Total return · 5 years
-65.95%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$2.25B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
96.68%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

TELEFLEX INCORPORATED Overview

View more →

(m)

(m)

SEC CIK
96943
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
550 E SWEDESFORD RD, SUITE 400, WAYNE, Pennsylvania, 19087, United States
Fiscal year end
1231
Phone
610-225-6800

Similar stocks

Stock NameCountryMarket CapPE Ratio
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55